Dramamine for Kids

Manufacturer
Medtech Products Inc.
Effective date
2025-09-10
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 01:13:10

Label at a glance#

ProductDramamine for Kids
Active ingredientDIMENHYDRINATE
Label structure10 sections

Dosage and administration

to prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity to prevent or treat motion sickness, see below: Children 2 to under 6 years give ½ to 1 chewable tablet every 6-8 hours do not give more than 3 chewable tablets in 24 hours, or as directed by a doctor Children 6 to under 12 years give 1 to 2 chewable tablets every 6-8 hours do not give more than 6 chewable tablets in 24...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each tablet)

Dimenhydrinate 25 mg

Purpose

OTC - PURPOSE SECTION

Antiemetic

Use

INDICATIONS & USAGE SECTION

for prevention and treatment of these symptoms associated with motion sickness:

  • nausea
  • vomiting
  • dizziness

Warnings

WARNINGS SECTION

Do not use for

OTC - DO NOT USE SECTION

children under 2 years of age unless directed by a doctor

Ask a doctor before use if the child has

OTC - ASK DOCTOR SECTION

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma

Ask a doctor or pharmacist before use if the child is

OTC - ASK DOCTOR/PHARMACIST SECTION

taking sedatives or tranquilizers

When using this product

OTC - WHEN USING SECTION

  • marked drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a doctor before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • to prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity
  • to prevent or treat motion sickness, see below:
Children 2
to under 6

years
  • give ½ to 1 chewable tablet every 6-8 hours
  • do not give more than 3 chewable tablets
    in 24 hours, or as directed by a doctor
Children 6
to under 12

years
  • give 1 to 2 chewable tablets every 6-8 hours
  • do not give more than 6 chewable tablets in
    24 hours, or as directed by a doctor

Other information

OTHER SAFETY INFORMATION

  • Phenylketonurics: contains phenylalanine 0.84 mg per tablet
  • store at room temperature 68º - 77ºF (20º - 25ºC)
  • do not use if blister is broken or torn

Inactive ingredients

INACTIVE INGREDIENT SECTION

aspartame, citric acid, flavor, magnesium stearate, methacrylic acid copolymer, sorbitol

Questions?

OTC - QUESTIONS SECTION

1-800-382-7219 Dramamine.com

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

#1Pharmacist Recommended Brand
Ages 2 – 12

Safe, Precise Dose

Children’s Chewable Formula

Dramamine MOTION SICKNESS RELIEF for Kids

8 Chewable Tablets

Dye Free Grape Flavor

PRINCIPAL DISPLAY PANEL #1Pharmacist Recommended Brand Ages 2 – 12 Safe, Precise Dose Children’s Chewable Formula Dramamine MOTION SICKNESS RELIEF for Kids 8 Chewable Tablets Dy...PRINCIPAL DISPLAY PANEL #1Pharmacist Recommended Brand Ages 2 – 12 Safe, Precise Dose Children’s Chewable Formula Dramamine MOTION SICKNESS RELIEF for Kids 8 Chewable Tablets Dy...

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1245184dimenhyDRINATE 25 MG Chewable TabletPSN4
1245186Dramamine 25 MG Chewable TabletPSN4
1245186dimenhydrinate 25 MG Chewable Tablet [Dramamine]SBD4
1245184dimenhydrinate 25 MG Chewable TabletSCD4
1245186Dramamine 25 MG Chewable TabletSY4
1245186Dramamine for Kids 25 MG Chewable TabletSY4

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DIPHENHYDRAMINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0e2e0f88-b076-afe1-4bdd-32bca4375becProduct name320250127
3e48c9c4-918d-5d23-2f0b-d2398b06be54Product name120140508
6084a4f4-5437-c9a5-caec-5361ee075a59Product name120140508
865c72dd-0d94-daac-f728-ddd4ded2a79eProduct name120140508
90c5639a-61b0-88d6-ddcf-21888e94869aProduct name120140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63029-904-012025-09-09C16284748780-19d75b9d0-3b32-f424-e053-dadaa90a57ceDramamine for Kids
63029-904-012020-01-31C16284748780-19d75b9d0-3b32-f424-e053-dadaa90a57ceDramamine for Kids

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63029-904-01Dramamine for Kids1 in 1 BLISTER PACKTABLET, CHEWABLE14
63029-904-01Dramamine for Kids8 in 1 CASETABLET, CHEWABLE84

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63029-904-01EA - Each63029-904216a5c51-e4ee-4248-bf9f-63116c03596812022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
DIMENHYDRINATEACTIVE INGREDIENTJB937PER5C3
DIPHENHYDRAMINEACTIVE MOIETY8GTS82S83M3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR13
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I303
SORBITOLINACTIVE INGREDIENT506T60A25R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63029-90463029-904-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 8 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, CHEWABLE / ORAL195 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, CHEWABLE / ORAL195 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE / ORAL127 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, CHEWABLE / ORAL7 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, CHEWABLE / ORAL7 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, CHEWABLE / ORAL3555 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE / ORAL127 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, CHEWABLE / ORAL3555 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Dramamine for KidsDIMENHYDRINATEMedtech Products Inc.12bc3f17-ed62-4d0d-9b1e-3835579e711b2025-09-10WarningsExact identifier
ndc (package): 63029-904-01
ndc (product): 63029-904
ndc11 (package): 63029090401
spl id: 5bdaae92-e9c3-401c-a31c-5d0218b0481f
spl set id: 12bc3f17-ed62-4d0d-9b1e-3835579e711b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.